August 25, 2020
Proteostasis Therapeutics, Inc. Investigation
We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Proteostasis Therapeutics, Inc. (“PTI” or the “Company”) (NASDAQ: PTI)
Join Case →